The VP of R&D will have end-to-end responsibility for managing the R&D portfolio, ensuring that projects and programs are appropriately prioritized, resourced, governed, and executed against clearly defined milestones, timelines, budgets, and business objectives. Our industry-leading precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology, and infectious disease.